Prednisolone

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Prednisolone and local guidelines before prescribing.

Glucocorticoid

Mechanism

Glucocorticoid with anti-inflammatory and immunosuppressive effects.

Uses

Asthma and COPD exacerbation, giant cell arteritis, polymyalgia, inflammatory bowel disease, vasculitis, nephrotic syndrome.

Dosing

4 more dose entries from the chapters
  • Prednisolone | Asthma attack: 40–50 mg for at least 5 days. COPD exacerbation: 30 mg for 5 days. ABPA: tapering course.
    Respiratory: Airways Disease
  • Acute severe asthma | Oxygen to 94–98%; salbutamol 5 mg and ipratropium 0.5 mg nebulised (oxygen-driven); prednisolone 40–50 mg
    Respiratory: Emergencies
  • COPD with hypercapnic acidosis | Controlled oxygen to 88–92%; nebulisers; prednisolone 30 mg; NIV if pH below 7.35 and PaCO2 above 6.5 kPa persist
    Respiratory: Emergencies
  • First line: Oral prednisolone (e.g. 20–40 mg daily for pulmonary disease), tapered to the lowest effective dose over 6–12 months or more. Give bone protection.
    Respiratory: Interstitial Lung Disease

Side effects

Hyperglycaemia, insomnia, mood change, weight gain, osteoporosis, adrenal suppression, infection, gastric irritation.

Interactions

NSAIDs raise GI bleed risk; enzyme inducers reduce effect; warfarin and antidiabetic drug effects change.

Contraindications and cautions

Untreated systemic infection

Monitoring

Glucose, BP, bone health

Pregnancy and breastfeeding

Acceptable

Renal and hepatic impairment

No adjustment

Overdose and reversal

Supportive

Special advice

Steroid card and sick-day rules when long term; bone protection with prolonged courses; taper if more than 3 weeks.

More from the textbook: uses, cautions and other points
Where it is discussed in the book